Topic
Interventional Oncology (IO)
Podcasts
Vascular & IR # 682Oct 9, 2026Liquid Embolization Techniques for Treating Hypervascular Tumors
How do you devascularize a hypervascular tumor when the vessels feeding it are too small to catheterize? On this episode of BackTable Podcast, Dr. Kavi Krishnasamy is joined by Dr. Resmi Charalel and Dr. Milan Patel to walk through seven real-world cases where non-adhesive hydrogel liquid embolics made the difference. They break down patient selection, case planning, and how to deploy these agents for safe, efficient devascularization when traditional approaches fall short.
- Vascular & IR # 676Sep 18, 2026
Use of Tunneled Catheters for Ascites & Effusions Management
When is it time to move from repeat drainage to a tunneled catheter for managing pleural effusions or ascites? On this episode of BackTable Podcast, Dr. Neil Jain interviews Dr. Marco Ertreo, interventional radiologist and IR residency program director at Strong Memorial Hospital, University of Rochester, about best practices for tunneled catheter management in both the chest and abdomen. They discuss the triggers for placing a tunneled catheter, patient selection, placement technique, home drainage protocols, complication management, and the unique considerations for malignant versus cirrhotic ascites.
- Vascular & IR # 673Sep 8, 2026
Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures.
Industry # 107Sep 1, 2026Keeping Up with the Field in Interventional Radiology
What does a personal learning system look like when you have to build it yourself, in your first year out of training? On this episode of the BackTable Industry Podcast, host Anish Parikh sits down with Dr. Gregg Khodorov, a newly graduated interventional radiologist joining IR Centers in South Jersey after his integrated IR/DR residency at Thomas Jefferson University Hospital, to discuss the realities of keeping up with the field in early practice. They explore the transition from the structure of residency to the challenge of self-directed learning, including board preparation, endovascular simulation, tumor boards, podcasts, and the AI-powered study tools Dr. Khodorov created for himself.
- Vascular & IR # 659Jun 30, 2026
Combination Therapy for Hepatocellular Carcinoma
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional guidelines suggest your hands are tied? In this episode of the 2026 HCC Creator Weekend™, medical oncologist Dr. Lingling Du (Ochsner Health) and interventional radiologist Dr. Beau Toskich (Mayo Clinic Florida) join Dr. Tyler Sandow to break down patient selection, timing strategies, and the practical application of clinical trial outcomes when integrating Y90 radioembolization and immunotherapy in HCC management.
- Vascular & IR # 657Jun 23, 2026
Advanced Techniques in Y90 Cancer Treatment
What do you do when Y-90 doesn’t deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™, host Dr. Tyler Sandow is joined by Drs. Beau Toskich and Juan Gimenez to discuss the technical challenges and troubleshooting strategies that can make or break a Y-90 radioembolization case. Together, they explore innovative approaches like the PREDATr technique, share tips for reducing complications, and offer guidance on optimizing outcomes for patients with complex liver tumors.
- Vascular & IR # 655Jun 16, 2026
Managing Large Liver Tumors: Strategies & Challenges
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent therapeutic pathways where palliation was once deemed the only option? In this episode of the 2026 HCC Creator Weekend™, interventional radiologists Dr. Chris Malone (WashU), Dr. Tyler Sandow (Ochsner Health), and Dr. Beau Toskich (Mayo Clinic Florida) join host Dr. Zach Berman for a case-based discussion on advanced dosimetric strategies and embolization approaches for large and complex HCC lesions.
Tumor Board # 66Jun 16, 2026Managing Complications in Pancreatic Cancer
How do seasoned clinicians navigate the complex web of complications that accompany pancreatic cancer? In this episode of BackTable Tumor Board, Drs. Greg Botta, Rebekah White, and Zachary Berman discuss real-world strategies for managing pain, digestive complications, and the many challenges patients face. They explore multidisciplinary approaches, emphasizing the importance of tailored pain management, careful use of enzyme supplementation, and anticipating both surgical and medical risks, especially after procedures like the Whipple.
- Vascular & IR # 653Jun 9, 2026
Radiation Lobectomy Techniques & Downstaging for HCC
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases? In this episode of the BackTable 2026 HCC Creator Weekend™, host Dr. Kavi Krishnasamy is joined by interventional radiologists Dr. Beau Toskich and Dr. Chris Malone to explore how downstaging and radiation lobectomy with Y90 are creating new surgical and transplant opportunities for patients with limited future liver remnants. They discuss Y90’s role as a “test of time” for tumor biology, strategies to prevent post-hepatectomy liver failure, and the ongoing challenge of recurrence even after R0 resection in cirrhotic livers.
- Vascular & IR # 651Jun 2, 2026
Radioembolization Workflow: Insights & Best Practices
What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this episode of the BackTable 2026 HCC Creator Weekend™, host Dr. Zach Berman is joined by Drs. Nima Kokabi and Kirema Garcia-Reyes to break down the systems, workflows, and strategies that drive successful radioembolization centers. The conversation focuses on overcoming referral and insurance delays, implementing multidisciplinary clinics, and using tools like single-session Y90 and routine post-treatment dosimetry to reduce treatment times and improve outcomes.
- Vascular & IR # 649May 27, 2026
Y90 Radioembolization Dosimetry: Techniques & Challenges
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, interventional oncologists Dr. Riad Salem, Dr. Nima Kokabi, and Dr. Zach Berman examine modern Y90 dosimetry, from the decline of body-surface-area calculations to newer strategies that tailor treatment intensity to tumor burden, liver reserve, and clinical intent.
- Vascular & IR # 644May 12, 2026
Optimizing Liver Transplant Pathways & Decision-Making
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account for liver reserve, tumor biology, and evolving biomarkers. In this episode of the BackTable Podcast 2026 HCC Creator Weekend™, abdominal transplant surgeon Dr. Ari Cohen (Ochsner Health) and transplant hepatologist Dr. Neil Mehta (UCSF) join host Dr. Kavi Krishnasamy to map out strategies for effective multidisciplinary treatment and transplantation planning in HCC.
- Vascular & IR # 642May 7, 2026
Exploring CPN & Radiation Segmentectomy in Liver Cancer
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is cracking the code on complete tumor kill in hepatocellular carcinoma (HCC) bridging therapy. Host Dr. Kavi Krishnasamy is joined by Dr. Zach Berman and Dr. Beau Toskich to break down the latest multi-center research from COBRAS (Consortium on Bridging Radiation Segementectomy with Glass Microspheres Before Transplant), setting a new standard for bridging therapy that offers actionable strategies to improve outcomes.
- Vascular & IR # 641May 5, 2026
Understanding BCLC Updates & Guidelines
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their treatment strategies to accommodate the newest evidence? In this episode of the BackTable Podcast 2026 HCC Creator Weekend™, Dr. Neil Mehta of UCSF and Dr. Riad Salem of Northwestern Medicine join host Dr. Tyler Sandow to explore the complexities of hepatocellular carcinoma (HCC) therapies and the practical application of the latest global algorithms in balancing standardized therapeutic algorithms with individual patient factors.
- Vascular & IR # 640May 1, 2026
Hepatic Arteriography & C-Arm CT-Guided Liver Ablation
When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In this episode of the BackTable Podcast, Netherlands interventional oncologist Dr. Maarten (M.L.J.) Smits shares a step-by-step walkthrough of the new hepatic arteriography and C-arm CT–guided ablation (HepACAGA) technique, punctuated with a real-world case series at the end. Find out how intra-arterial contrast, cone-beam CT, and 3D needle guidance can improve tumor conspicuity, targeting accuracy, and ablation margin assessment within a single angiography suite.
- Vascular & IR # 639Apr 30, 2026
Advancements in Ablation Techniques for Liver Tumors
Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence? Host Dr. Kavi Krishnasamy sits down with interventional radiologists Dr. Christopher Malone (WashU, St. Louis) and Dr. Kirema Garcia-Reyes (Mount Sinai, NYC) at our 2026 HCC Creator Weekend™ in-studio in New Orleans to discuss modern liver ablation strategies for HCC and metastatic disease. The conversation centers on challenging real-world cases, combining multidisciplinary tumor board insights with hands-on experience using ablation confirmation software, radiofrequency, cryo, and microwave ablation.
- Vascular & IR # 632Apr 8, 2026
Career Choices That Work & Those That Don't Work
You may know him as the godfather of Y90, but you might not know what it took for Dr. Riad Salem to earn that title. Curiosity, ambition, critical thinking. High highs and devastating losses. This episode offers an inside look at how intellectual curiosity and patient focus fuel innovation in interventional radiology, featuring the man himself and hosts Dr. Tyler Sandow and Dr. Juan Gimenez in-studio in New Orleans.
- Tumor Board # 51Mar 17, 2026
Intratumoral Immunotherapy Injections for Melanoma
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional radiologists join forces to turn around patient outcomes? In this episode of the BackTable Podcast, medical oncologist Dr. Jennifer McQuade and interventional radiologist Dr. Rahul Sheth join host Dr. Tyler Sandow to discuss the growing evidence for intratumoral oncolytics as a therapeutic strategy for frontline immunotherapy-refractory melanoma and the interdisciplinary work that is required for successful implementation in practice.
- Vascular & IR # 622Mar 5, 2026
Intratumoral Immunotherapy Injections for Melanoma
When standard-of-care checkpoint blockade fails in metastatic melanoma, how can oncologists and interventional radiologists join forces to turn around patient outcomes? In this episode of the BackTable Podcast, medical oncologist Dr. Jennifer McQuade and interventional radiologist Dr. Rahul Sheth join host Dr. Tyler Sandow to discuss the growing evidence for intratumoral oncolytics as a therapeutic strategy for frontline immunotherapy-refractory melanoma and the interdisciplinary work that is required for successful implementation in practice.
- Vascular & IR # 621Mar 2, 2026
Techniques for Liver Metastases Ablation: Planning & Execution
With data increasingly positioning thermal ablation as a viable alternative to surgery for select liver metastases, the demands on the interventional oncologist have never been higher. Mastering the nuances of patient selection and precise margin assessment is now essential for ensuring effective disease control locally. In this episode of the BackTable Podcast, interventional radiologist Dr. Jonas Redmond of UC San Diego Health joins host Dr. Sabeen Dhand to discuss the current state of microwave ablation (MWA) in the management of oligometastatic liver disease, focusing on tumor assessment, preprocedural planning, and the integration of local and systemic therapies.
Bone & Sports # 91Jan 6, 2026Pathologic Fracture Fixation: Pelvic & Sacral Bone Stabilization Techniques
Your bony fixation technique can make (or break) a complex fracture case. In this episode of the BackTable MSK Podcast, host Kavi Krishnasamy welcomes Dr. Brandon Key, interventional radiologist at Medical College of Wisconsin (MCW) in Milwaukee, to discuss bone stabilization techniques in treating pathologic and non-pathologic fractures.
- Bone & Sports # 90Dec 30, 2025
Thermoprotection Techniques in Musculoskeletal Ablations Part 2
How to stay cool when a thermal ablation case gets complicated? Your toolbox can make all the difference. In this episode of the BackTable MSK Podcast, Dr. Alan Sag returns with host Dr. Jacob Fleming to continue the discussion on thermal protection in musculoskeletal ablation procedures. Part 2 focuses on real-world cases to provide practical insights and illustrate decision-making in complex thermal ablation cases.
- Vascular & IR # 602Dec 29, 2025
Managing Neuroendocrine Tumors in Interventional Radiology
What considerations drive your decision between bland embolization, TACE, and radioembolization in managing neuroendocrine tumors? In this BackTable episode, Dr. Daniel DePietro, interventional radiologist at the University of Pennsylvania joins host Dr. Kavi Krishnasamy for an in-depth discussion on the interventional management of neuroendocrine tumors.
- Vascular & IR # 599Dec 19, 2025
Lung Ablation: Techniques, Challenges & Best Practices
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central lung lesions that were previously untreatable. This episode of the 2025 NSCLC Creator Weekend™ series offers a deep dive into recent advancements in lung ablation and brachytherapy techniques for primary lung cancer.